Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Immunomodulation and tissue regeneration pathways" describe the complex set of signaling and cellular processes through which the immune system coordinates tissue repair after injury. Key roles are played by various immune cells, including macrophages, neutrophils, regulatory T cells, and natural killer cells, orchestrating the resolution of inflammation and initiation of tissue replacement and remodeling. The balance between pro-inflammatory and anti-inflammatory phases is crucial: initial inflammation clears debris and pathogens, while reparative/anti-inflammatory responses guide regeneration by recruiting progenitor cells and facilitating extracellular matrix remodeling. Disruption of this balance can lead to chronic inflammation, fibrosis, or inadequate healing[1][3][4][9]. These pathways are the focus of research in regenerative medicine and immunotherapy development, but they do not constitute a single molecular therapeutic target, rather involving numerous molecules (e.g., cytokines: IL-10, TGF-β; transcription factors: STATs; membrane receptors: TGF-β receptor, JAK/STAT)[1][4][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunomodulation and Tissue Regeneration Pathways.